Ming‐Mo Hou
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Wen‐Chi Chou (21 shared papers)Jen‐Shi Chen (22 shared papers)Siew Tzuh Tang (18 shared papers)Jason Chia-Hsun Hsieh (19 shared papers)Wen‐Cheng Chang (17 shared papers)Fur‐Hsing Wen (16 shared papers)Yee Chao (3 shared papers)Yoon‐Koo Kang (3 shared papers)
- Journals
- Journal of Pain and Symptom Management (9 papers)Annals of Oncology (6 papers)Psycho-Oncology (4 papers)The Oncologist (3 papers)Biomedical Journal (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ming‐Mo Hou
56 papers receiving 2.4k citations
Ming‐Mo Hou's Hit Papers
Peers
Comparison fields: 5 of 72
- Hepatology 1.2k
- Oncology 723
- Pharmacy 32
- Public Health, Environmental and Occupational Health 200
- Cancer Research 54
Countries citing papers authored by Ming‐Mo Hou
This map shows the geographic impact of Ming‐Mo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Mo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Mo Hou more than expected).
Fields of papers citing papers by Ming‐Mo Hou
This network shows the impact of papers produced by Ming‐Mo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Mo Hou. The network helps show where Ming‐Mo Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Mo Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib Hit paper breakdown → | 2020 | 1068 |
| 2 | Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Hit paper breakdown → | 2024 | 239 |
| 3 | 2019 | 204 | |
| 4 | 2020 | 119 | |
| 5 | 2022 | 55 | |
| 6 | 2014 | 54 | |
| 7 | 2015 | 54 | |
| 8 | 2017 | 43 | |
| 9 | 2016 | 39 | |
| 10 | 2020 | 32 | |
| 11 | 2016 | 24 | |
| 12 | 2017 | 24 | |
| 13 | 2021 | 24 | |
| 14 | 2017 | 23 | |
| 15 | 2018 | 21 | |
| 16 | 2016 | 20 | |
| 17 | 2019 | 20 | |
| 18 | 2024 | 20 | |
| 19 | Proton beam radiotherapy combined with anti-PD1/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma. | 2022 | 19 |
| 20 | 2021 | 18 |
About Ming‐Mo Hou
Ming‐Mo Hou is a scholar working on Hepatology, Oncology, Public Health, Environmental and Occupational Health, Clinical Psychology and Obstetrics and Gynecology, having authored 58 papers that have together received 2.4k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Immunotherapy and Biomarkers (5 papers), Grief, Bereavement, and Mental Health (5 papers), Esophageal Cancer Research and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Immunotherapy and Immune Responses (3 papers) and Endometrial and Cervical Cancer Treatments (2 papers). The work is most often cited by research in Hepatology (1.2k citations), Oncology (723 citations), Pharmacy (32 citations), Public Health, Environmental and Occupational Health (200 citations) and Cancer Research (54 citations). Ming‐Mo Hou has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wen‐Chi Chou, Jen‐Shi Chen, Siew Tzuh Tang, Jason Chia-Hsun Hsieh, Wen‐Cheng Chang, Fur‐Hsing Wen, Yee Chao, Yoon‐Koo Kang, Ryoko Kuromatsu and Michihisa Moriguchi. Their work appears in journals such as Journal of Pain and Symptom Management, Annals of Oncology, Psycho-Oncology, The Oncologist and Biomedical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.